-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Nuvalent, Lowers Price Target to $145

Benzinga·12/19/2025 16:22:32
语音播报
JP Morgan analyst Anupam Rama maintains Nuvalent (NASDAQ:NUVL) with a Overweight and lowers the price target from $147 to $145.